AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2019
Dec 17, 2019
32134_dirs_2019-12-16_b0c019c9-1f24-4443-b732-373fc3b420cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2019-12-12
Reporting Person: Myriam Curet (Director)
More from NEKTAR THERAPEUTICS
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20